Training and Career Development: Brain Development, Aging, and Cognition – T32A
The Career Development Study Section in the Neuropathology C (NPC) branch will review applications responding to various K award mechanisms, including K99, K01, K02, K22, K23, K24, etc. The study section covers topics on neurobiology of central nervous system (CNS) development, learning and memory, higher order cognition. Applications address aging and aging-associated neurodegenerative disorders in human and clinical studies are also covered in this panel.
Review Dates
A roster for the panel will be posted here, at least 30 days prior to the review meeting
Topics
- Mechanisms in brain development and developmental disorders, including molecular and cellular basis, neuroimmune regulation and dysregulation of brain structural and functional development in animals and humans.
- Neural and synaptic mechanisms of learning, memory, and decision-making, including memory formation, consolidation, and retrieval; synaptic plasticity and cellular/molecular mechanisms; electrophysiology, anatomical circuit mapping, epigenetics; and behavioral physiology and pathological states (e.g., fear memory consolidation, PTSD).
- Neural circuitry and computational modeling of cognition, encompassing circuitry-level studies of cognition and executive functions.
- Sleep, circadian rhythms, and their behavioral and cognitive impacts, including mechanisms of sleep regulation; circadian rhythms and clock genes; modulation by stress and environmental factors; interactions with behavior such as feeding, social interaction, sleep–wake cycles, and hibernation; effects of sleep and aging on memory in humans; and eating and sleep disorders.
- Human studies of geriatric syndromes and late-life multisystem disorders, including frailty, functional decline, resiliency to stressors, and interventions (e.g., diet, exercise, rehabilitation) affecting aging and lifespan.
- Cognitive disorders and neurodegeneration in aging, focusing on human and clinical studies on mechanisms, diagnosis, progression, biomarkers, and interventions for Alzheimer’s and related dementias and other neurodegenerative disorders.
